Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled immunotherapy with Dermatophagoides mixture extract for mild-moderate persistent asthma
2005-001573-10Phase 4Completed
- Sponsor
- ALK-Abelló
- Start
- May 2006
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma and allergic rhinitis (AR) comparing Pangramin Plus dermatophagoides mixture immunotherapy with Placebo (2 arms). Primary endpoint: Inhaled corticosteroid dose required for asthma control. Started May 2006; status: completed.
02
Drugs
dermatophagoides pteronyssinus extract
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on 2005-001573-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001573-10.